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A number of studies have delineated the role of enteric factors， often termed 
the enteroinsular axis， in the modulation of insulin secretion 1~3). It is generally 
agreed that one or more of the insulinotropic polypeptide hormones of the intestine 
(so-called incretin) are involved. The currently postulated incretin includes gastric 
inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-l) 4~7). Investigations 
on the distribution of GLP-1-like immunoreactivity in the gastrointestinal tract 
showed highest concentrations in the terminal ileum and colon in the rat 8). 
However， the role for the terminal ileum and colon in the enteroinsular axis has 
remained to be elucidated. In order to elucidate this issue， insulin response to 
intravenous or intragastric glucose ingestion was investigated in the rat with 
colectomy in the present study. 
Materials and methods 
Animals and operation 
Male Wistar albino rats weighing approximately 250g (6 -8 weeks) were used 
in the present study. The rats were anesthetized with intraperitoneal pentobarbital 
sodium (40 mg/kg) after an overnight fast. The abdomen was opened and t1;le 
terminal ileum (3 cm apart from the cecum) and the colon (4 cm apart from the 
anus) were ligated. The pancreas was carefully removed from the colon. Then the 
terminal ileum and colon were resected. The polyethylene cannula was inserted into 
the ileum， and intestinal fluid was drained. In control rats， the abdomen was 
opened and the polyethylene cannula was inserted into the same portion of the 
terminal ileum in a similar manner. 
IntrafJt.αstric inlusion 01 glucose 
Thirty minutes after the operation， glucose solution (1.5 g/kg in a 20 g 
solution) was bolus infused into the stomach using a syringe and the blood was 
drawn at 0， 30， 60， and 120 min from the portal and the femoral vein. 
Intravenous inlusi仰 01glucose 
Glucose solution (0.5 g/kg in a 20弘solution)was bolus infused into the left 
femoral vein， and the blood was drawn at 0， 5， 15， and 30 min from the portal and 
the right femoral vein. The samples were centrifuged and the plasma was stored at 
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-20 oC until the time of hormone assay. During the studies， the body temperature 
was maintained at 3TC with a hot plate. 
Measuremenis 
Blood glucose was measured by a glucose oxidase method. Plasma insulin was 
measured by radioimmunoassay using rat insulin standard. The sensitivity of this 
assay was 2μU/ml， and intraassay and interassay coe百icientsof variation were less 
than 10覧.
5t，αtistics 
Data are expressed as means + SD. Statistical analyses were made using analysis 
of variance and two-tailed Student's nonpaired t teat. 
Results 
lnsulin response to intragastric glucose 
As shown in Table 1， portal and femoral blood glucose levels after glucose 
ingestion were not significantly different between colectomized rats and control rats. 
Portal and femoral plasma insulin levels were significantly lower in colectomized rats 
than those in control rats at 30 and 60 min. 
Table 1 Blood glucose and plasma insulin response to intragastric glucose 
femoral vein portal vein 
O 30 60 120min O 30 
control (nニ7)
BG (mg/dl) 110士10178土25201ごと53 165:t30 109:t10 184:t29 
IRI (μU/ml) 8士 2 43:t1 30士6 16士5 24:t5 128土46
colectomy (n= 7) 
BG (昭/dl) 112土10157土24221士36 152土33 116:t10 158:t13 
IRI (μU/ml) 8士2 28:t7* 20土6* 19ごと5 29:t7 64:t29* 
colectomy: rats resected the terminal ileum and colon 
BG: blood glucose， IRI: plasma insulin 
*p<0.05， significant1y different from control. 
lnsulin res仰 1Seto intravenous glucose 
60 
184土40
123土38
216土28
6土31*
120min 
180:t32 
67土21
154:t36 
34士15
As shown in Table 2， portal and femoral blood glucose responses after the 
venous infusion were similar in both groups of rats. Femoral plasma insulin level 
was significant1y lower in colectomized rats than those in control rats at 5 and 15 
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min， and portal insulin level was significantly lower in colectomized rats than those 
in control rats at 5 min. 
Table 2 Blood glucose and plasma insulin response to intravenous glucose 
femoral vein 
O 5 15 30min 
control (n= 7) 
BG (mg/dl) 110:t10 245:t41 216:t30 124:t19 
IRI (μU/ml) 9:t2 29:t7 52土12 19:t6 
colectomy (n= 7) 
BG (mg/dl) 110土1 270:t42 232土39 119:t19 
IRI (μU/ml) 9士2 19士5*30:t9* 19士5
colectomy: rats resected the terminal ileum and colon 
BG: blood glucose， IRI: plasma insulin 
*p<0.05， significant1y di旺erentfrom control. 
Discussion 
portal vein 
O 5 15 30min 
108ごと10237ごと38 208:t35 129士20
25土6 73:t2 115:t31 5ごと19
116:t1 282:t49 222土36 125:t20 
30土8 42:t14* 88土24 48土16
The present study clearly demonstrated that insulin response to both infusion of 
intragastric and intravenous glucose was significantly inhibited in rats resected the 
terminal ileum and colon. Significantly lower level of portal insulin suggests the 
decrease in insulin secretion from the pancreatic B cell in colectomized rats. Similar 
degree of insulin response in portal blood and femoral blood indicates that hepatic 
extraction of insulin is not significantly changed in colectomized rats. Because the 
concentration of GLP-l immunoreactivity is markedly higher in the terminal ileum 
and the colon 8)， and because GLP-l has a strong insulinotropic effect in the rat 9~1O) ， 
the decreased GLP-l secretion by colectomy may be involved in the decrease in 
insulin to glucose in the colectomized rats. Although insulin release in colectomized 
rats was significantly decreased， blood glucose level in them did not elevate. Such 
decrease in insulin secretion may not have reached the level for impairing glucose 
tolerance. 
It may be complicated that pancreatic and/or portal blood flow is changed by 
colectomy， and that other insulinotropic hormone(s) is released from the terminal 
ileum and/or colon. These issues have remained to be elucidated. 1 believe that this 
is the first report suggesting the important role for the terminal ileum and colon in 
the enteroinsular axis. 
Because GLP-l like immunoreactivity was identified in colorectal enteroglucagon 
cells in human 11)， and because GLP-l was suggested to be a physiological incretin 
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in human 12)， the terminal ileum and the colon may have an important role in 
insulin secretion in human as well as in the rat. Further studies should be 
necessary to resolve this issue. 
Summary 
1nvestigations on the distribution of glucagon-like peptide呼1-likeimmunoreactivity， 
which is one of the most pro bable candidates for incretin， in the gastro-intestinal 
tract showed highest concentrations in the terminal ileum and colon. To elucidate 
the possible role for the terminal ileum and colon in the enteroinsular axis， insulin 
response to glucose was investigated in rats resected the terminal ileum and colon. 
Although portal and femoral blood glucose levels after glucose ingestion were not 
significantly different between colectomized and control rats， portal and femoral 
plasma insulin responses to intragastric (1.5 g/kg) and intravenous (0.5 g/kg) 
glucose were significantly reduced in colectomized rats compared with those in 
control rats. These results suggest that the terminal ileum and/or colon have an 
important role in enteroinsular axis in the rat. 
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